SS Innovations International, a leading surgical robot developer, announced the appointment of Naveen Kumar Amar as its new Chief Financial Officer (CFO). Amar officially stepped into the role, succeeding Vishwa Srivastava, who had served as interim CFO since July.
Srivastava will now transition to the position of CEO for the Asia Pacific region, continuing to guide the company’s regional growth.Amar brings a wealth of experience to SS Innovations, with a robust background in finance across multiple industries.
His previous roles include Head of Finance and Commercial at SpiceXpress, Global CFO at software provider Munch Ado India, and Senior Vice President of Finance and Compliance at vaccine manufacturer MSD Wellcome Trust Hilleman Laboratories. He also held the position of CFO for India and Australia at telecommunications firm EDirect Proprietary and served as India Manager of Financial Consolidation for GE India. Most recently, Amar provided virtual CFO services to clients in the U.S., Canada, and the U.K.
ALSO READ: WNS UNVEILS AI-POWERED ATOM ALATFORM FOR GLOBAL FINANCE TRANSFORMATION
The appointment comes as SS Innovations intensifies its global expansion efforts for the SSi Mantra surgical robot, marketed as a cost-effective alternative to Intuitive Surgical’s da Vinci system. Currently approved in seven countries, including India, Indonesia, and the Philippines, the company is pursuing regulatory approvals in the U.S. and Europe. SS Innovations anticipates receiving Europe’s CE mark in the first half of 2026 and plans to submit a 510(k) application to the U.S. Food and Drug Administration by late October.
CEO Sudhir Srivastava praised Amar’s appointment, noting, “We are thrilled to welcome a seasoned financial executive of his caliber to our leadership team as we expand the global presence of our advanced, cost-efficient SSi Mantra surgical robotic system.” With Amar’s expertise in building top-tier finance operations across diverse geographies, SS Innovations is poised to strengthen its position in the competitive medical technology market.
